Showing results (371-380 of 423) with videos related to

Sort By:
Pageof 43
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 5, 2025
Atomoxetine plus oxybutynin for symptomatic snoring and airflow limitation in individuals without moderate-to-severe obstructive sleep apneaNicole Calianese, Lauren B Hess, Daniel Vena, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2015
Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1Justin K Murray, Kaustav Biswas, J Ryan Holder, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2007
The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancerBlaise Lippa, Goss S Kauffman, Joel Arcari, et al.
Annals of the American Thoracic Society|July 6, 2023
Drive versus Pressure Contributions to Genioglossus Activity in Obstructive Sleep ApneaLaura K Gell, Daniel Vena, Kevin Grace, et al.
Plos One|September 5, 2014
Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to painJacinthe Gingras, Sarah Smith, David J Matson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 10, 1996
Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophyB Hess, P Saftig, D Hartmann, et al.
Cancer Research|August 9, 2003
The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cellsE Gabriella Barbacci, Leslie R Pustilnik, Ann Marie K Rossi, et al.
The Journal of Biological Chemistry|March 11, 2008
Small molecule activator of the human epithelial sodium channelMin Lu, Fernando Echeverri, Dalia Kalabat, et al.
Pageof 43